Challenges & Opportunities For Comorbid Substance Use Disorder & Major Depressive Disorder
There are approximately 8.5 million adults living in the United States with co-occurring mental illness and substance use disorder (SUD).1 During this PsychU presentation, the speakers describe the impact of drugs of abuse on Major Depressive Disorder (MDD) symptomatology, discuss how phases of recovery can impact MDD, and identify considerations for treatment of comorbid SUD and MDD.
Featuring:
Robin Nelson, MD
Psychiatrist, DGR Comprehensive Behavioral Health, LLC
Roueen Rafeyan, MD
Psychiatrist, Chief Medical Officer for Gateway Foundation Addiction Treatment Centers
Robin Nelson, MD, is the Former …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.